(TSN) Tyson Foods - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US9024941034
Stock: Beef, Pork, Chicken, Prepared Foods
Total Rating 50
Risk 86
Buy Signal -0.15
| Risk 5d forecast | |
|---|---|
| Volatility | 22.3% |
| Relative Tail Risk | -4.83% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.26 |
| Alpha | -1.25 |
| Character TTM | |
|---|---|
| Beta | 0.172 |
| Beta Downside | 0.161 |
| Drawdowns 3y | |
|---|---|
| Max DD | 26.40% |
| CAGR/Max DD | 0.23 |
EPS (Earnings per Share)
Revenue
Risks
Fundamental:
P/E ratio: 116.0536
Description: TSN Tyson Foods March 03, 2026
Tyson Foods, Inc. (NYSE: TSN) is a global food company headquartered in Springdale, Arkansas, operating through Beef, Pork, Chicken, and Prepared Foods segments. As a vertically integrated protein processor, the company manages the supply chain from raising poultry and processing live livestock to manufacturing value-added consumer products, a model designed to capture value at multiple production stages.
The company’s portfolio includes fresh, frozen, and refrigerated items such as breaded chicken, bacon, sausages, and ready-to-eat meals sold under brands like Tyson, Jimmy Dean, Hillshire Farm, and Ball Park. Distribution channels span grocery retailers, wholesalers, chain restaurants, and industrial food processors. For a detailed breakdown of Tysons financial health and valuation metrics, you can verify the latest data on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 200.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -0.34 > 1.0 |
| NWC/Revenue: 6.00% < 20% (prev 9.89%; Δ -3.89% < -1%) |
| CFO/TA 0.06 > 3% & CFO 2.07b > Net Income 200.0m |
| Net Debt (7.08b) to EBITDA (2.24b): 3.16 < 3 |
| Current Ratio: 1.53 > 1.5 & < 3 |
| Outstanding Shares: last quarter (345.0m) vs 12m ago -3.36% < -2% |
| Gross Margin: 5.96% > 18% (prev 0.07%; Δ 588.9% > 0.5%) |
| Asset Turnover: 150.4% > 50% (prev 143.7%; Δ 6.67% > 0%) |
| Interest Coverage Ratio: 1.97 > 6 (EBITDA TTM 2.24b / Interest Expense TTM 433.0m) |
Altman Z'' 3.52
| A: 0.09 (Total Current Assets 9.51b - Total Current Liabilities 6.20b) / Total Assets 36.02b |
| B: 0.52 (Retained Earnings 18.55b / Total Assets 36.02b) |
| C: 0.02 (EBIT TTM 851.0m / Avg Total Assets 36.66b) |
| D: 1.03 (Book Value of Equity 18.45b / Total Liabilities 17.86b) |
| Altman-Z'' Score: 3.52 = A |
Beneish M -2.84
| DSRI: 1.02 (Receivables 2.43b/2.32b, Revenue 55.13b/53.61b) |
| GMI: 1.22 (GM 5.96% / 7.27%) |
| AQI: 1.01 (AQ_t 0.48 / AQ_t-1 0.48) |
| SGI: 1.03 (Revenue 55.13b / 53.61b) |
| TATA: -0.05 (NI 200.0m - CFO 2.07b) / TA 36.02b) |
| Beneish M-Score: -2.84 (Cap -4..+1) = A |
What is the price of TSN shares?
As of March 05, 2026, the stock is trading at USD 62.92 with a total of 2,358,208 shares traded.
Over the past week, the price has changed by +1.31%, over one month by -2.42%, over three months by +12.98% and over the past year by +7.68%.
Over the past week, the price has changed by +1.31%, over one month by -2.42%, over three months by +12.98% and over the past year by +7.68%.
Is TSN a buy, sell or hold?
Tyson Foods has received a consensus analysts rating of 3.57.
Therefor, it is recommend to hold TSN.
- StrongBuy: 3
- Buy: 2
- Hold: 9
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the TSN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 69.1 | 9.8% |
| Analysts Target Price | 69.1 | 9.8% |
TSN Fundamental Data Overview March 03, 2026
P/E Trailing = 116.0536
P/E Forward = 16.4474
P/S = 0.415
P/B = 1.2696
P/EG = 1.0277
Revenue TTM = 55.13b USD
EBIT TTM = 851.0m USD
EBITDA TTM = 2.24b USD
Long Term Debt = 7.45b USD (from longTermDebt, last quarter)
Short Term Debt = 909.0m USD (from shortTermDebt, last quarter)
Debt = 8.36b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.08b USD (from netDebt column, last quarter)
Enterprise Value = 29.97b USD (22.88b + Debt 8.36b - CCE 1.28b)
Interest Coverage Ratio = 1.97 (Ebit TTM 851.0m / Interest Expense TTM 433.0m)
EV/FCF = 27.07x (Enterprise Value 29.97b / FCF TTM 1.11b)
FCF Yield = 3.69% (FCF TTM 1.11b / Enterprise Value 29.97b)
FCF Margin = 2.01% (FCF TTM 1.11b / Revenue TTM 55.13b)
Net Margin = 0.36% (Net Income TTM 200.0m / Revenue TTM 55.13b)
Gross Margin = 5.96% ((Revenue TTM 55.13b - Cost of Revenue TTM 51.84b) / Revenue TTM)
Gross Margin QoQ = 5.73% (prev 5.24%)
Tobins Q-Ratio = 0.83 (Enterprise Value 29.97b / Total Assets 36.02b)
Interest Expense / Debt = 1.24% (Interest Expense 104.0m / Debt 8.36b)
Taxrate = 29.13% (37.0m / 127.0m)
NOPAT = 603.1m (EBIT 851.0m * (1 - 29.13%))
Current Ratio = 1.53 (Total Current Assets 9.51b / Total Current Liabilities 6.20b)
Debt / Equity = 0.46 (Debt 8.36b / totalStockholderEquity, last quarter 18.02b)
Debt / EBITDA = 3.16 (Net Debt 7.08b / EBITDA 2.24b)
Debt / FCF = 6.40 (Net Debt 7.08b / FCF TTM 1.11b)
Total Stockholder Equity = 18.21b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.55% (Net Income 200.0m / Total Assets 36.02b)
RoE = 1.10% (Net Income TTM 200.0m / Total Stockholder Equity 18.21b)
RoCE = 3.32% (EBIT 851.0m / Capital Employed (Equity 18.21b + L.T.Debt 7.45b))
RoIC = 2.23% (NOPAT 603.1m / Invested Capital 27.04b)
WACC = 5.03% (E(22.88b)/V(31.24b) * Re(6.55%) + D(8.36b)/V(31.24b) * Rd(1.24%) * (1-Tc(0.29)))
Discount Rate = 6.55% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -1.42%
[DCF] Terminal Value 84.79% ; FCFF base≈1.17b ; Y1≈1.02b ; Y5≈811.8m
[DCF] Fair Price = 62.30 (EV 24.66b - Net Debt 7.08b = Equity 17.57b / Shares 282.1m; r=5.90% [WACC]; 5y FCF grow -16.12% → 2.90% )
EPS Correlation: -14.97 | EPS CAGR: -20.47% | SUE: 0.37 | # QB: 0
Revenue Correlation: 54.74 | Revenue CAGR: 2.35% | SUE: 1.44 | # QB: 1
EPS next Quarter (2026-06-30): EPS=1.01 | Chg7d=+0.005 | Chg30d=+0.030 | Revisions Net=+2 | Analysts=9
EPS current Year (2026-09-30): EPS=3.88 | Chg7d=-0.040 | Chg30d=+0.024 | Revisions Net=+7 | Growth EPS=-5.7% | Growth Revenue=+3.6%
EPS next Year (2027-09-30): EPS=4.42 | Chg7d=-0.017 | Chg30d=+0.043 | Revisions Net=+1 | Growth EPS=+13.8% | Growth Revenue=+0.9%
[Analyst] Revisions Ratio: +0.25 (5 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.1% (Discount Rate 7.9% - Earnings Yield 0.9%)
[Growth] Growth Spread = -4.7% (Analyst 2.4% - Implied 7.1%)
P/E Forward = 16.4474
P/S = 0.415
P/B = 1.2696
P/EG = 1.0277
Revenue TTM = 55.13b USD
EBIT TTM = 851.0m USD
EBITDA TTM = 2.24b USD
Long Term Debt = 7.45b USD (from longTermDebt, last quarter)
Short Term Debt = 909.0m USD (from shortTermDebt, last quarter)
Debt = 8.36b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.08b USD (from netDebt column, last quarter)
Enterprise Value = 29.97b USD (22.88b + Debt 8.36b - CCE 1.28b)
Interest Coverage Ratio = 1.97 (Ebit TTM 851.0m / Interest Expense TTM 433.0m)
EV/FCF = 27.07x (Enterprise Value 29.97b / FCF TTM 1.11b)
FCF Yield = 3.69% (FCF TTM 1.11b / Enterprise Value 29.97b)
FCF Margin = 2.01% (FCF TTM 1.11b / Revenue TTM 55.13b)
Net Margin = 0.36% (Net Income TTM 200.0m / Revenue TTM 55.13b)
Gross Margin = 5.96% ((Revenue TTM 55.13b - Cost of Revenue TTM 51.84b) / Revenue TTM)
Gross Margin QoQ = 5.73% (prev 5.24%)
Tobins Q-Ratio = 0.83 (Enterprise Value 29.97b / Total Assets 36.02b)
Interest Expense / Debt = 1.24% (Interest Expense 104.0m / Debt 8.36b)
Taxrate = 29.13% (37.0m / 127.0m)
NOPAT = 603.1m (EBIT 851.0m * (1 - 29.13%))
Current Ratio = 1.53 (Total Current Assets 9.51b / Total Current Liabilities 6.20b)
Debt / Equity = 0.46 (Debt 8.36b / totalStockholderEquity, last quarter 18.02b)
Debt / EBITDA = 3.16 (Net Debt 7.08b / EBITDA 2.24b)
Debt / FCF = 6.40 (Net Debt 7.08b / FCF TTM 1.11b)
Total Stockholder Equity = 18.21b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.55% (Net Income 200.0m / Total Assets 36.02b)
RoE = 1.10% (Net Income TTM 200.0m / Total Stockholder Equity 18.21b)
RoCE = 3.32% (EBIT 851.0m / Capital Employed (Equity 18.21b + L.T.Debt 7.45b))
RoIC = 2.23% (NOPAT 603.1m / Invested Capital 27.04b)
WACC = 5.03% (E(22.88b)/V(31.24b) * Re(6.55%) + D(8.36b)/V(31.24b) * Rd(1.24%) * (1-Tc(0.29)))
Discount Rate = 6.55% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -1.42%
[DCF] Terminal Value 84.79% ; FCFF base≈1.17b ; Y1≈1.02b ; Y5≈811.8m
[DCF] Fair Price = 62.30 (EV 24.66b - Net Debt 7.08b = Equity 17.57b / Shares 282.1m; r=5.90% [WACC]; 5y FCF grow -16.12% → 2.90% )
EPS Correlation: -14.97 | EPS CAGR: -20.47% | SUE: 0.37 | # QB: 0
Revenue Correlation: 54.74 | Revenue CAGR: 2.35% | SUE: 1.44 | # QB: 1
EPS next Quarter (2026-06-30): EPS=1.01 | Chg7d=+0.005 | Chg30d=+0.030 | Revisions Net=+2 | Analysts=9
EPS current Year (2026-09-30): EPS=3.88 | Chg7d=-0.040 | Chg30d=+0.024 | Revisions Net=+7 | Growth EPS=-5.7% | Growth Revenue=+3.6%
EPS next Year (2027-09-30): EPS=4.42 | Chg7d=-0.017 | Chg30d=+0.043 | Revisions Net=+1 | Growth EPS=+13.8% | Growth Revenue=+0.9%
[Analyst] Revisions Ratio: +0.25 (5 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.1% (Discount Rate 7.9% - Earnings Yield 0.9%)
[Growth] Growth Spread = -4.7% (Analyst 2.4% - Implied 7.1%)